The integration of BNP and NT-proBNP into clinical medicine

The integration of BNP and NT-proBNP into clinical medicine

Bibliographic Details
Main Author:	Swiss Medical Weekly
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2007-01-01
Series:	Swiss Medical Weekly
Subjects:	heart failure Btype natriuretic peptide Dyspnoea
Online Access:	https://www.smw.ch/index.php/smw/article/view/686

Similar Items

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
by: Leonard Chiu, et al.
Published: (2024-04-01)

Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
by: Melissa A. Daubert, et al.
Published: (2021-05-01)

B-type natriuretic peptide (BNP): can it improve our management of patients with congestive heart failure?
by: Swiss Medical Weekly
Published: (2002-11-01)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
by: Isaac R. Whitman, et al.
Published: (2019-04-01)

Associations between diet quality and NT-proBNP in U.S. adults, NHANES 1999-2004
by: Ping Yang, et al.
Published: (2023-12-01)

ASA Status, <i>NPPA/NPPB</i> Haplotype and Coronary Artery Disease Have an Impact on BNP/NT-proBNP Plasma Levels
by: Markus Hahn, et al.
Published: (2022-02-01)

The Prognostic Role of Global Longitudinal Strain and NT-proBNP in Heart Failure Patients Receiving Cardiac Resynchronization Therapy
by: Nikolaos P. E. Kadoglou, et al.
Published: (2024-02-01)

Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
by: Jason Chami, et al.
Published: (2022-09-01)

Fasting Plasma Ketone Bodies Are Associated with NT-proBNP: A Potential Mechanism to Provide Fuel for the Failing Heart
by: Constantin L. Palm, et al.
Published: (2024-03-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)

Effects of Breed, Exercise, and a Two-Month Training Period on NT-proBNP-Levels in Athletic Dogs
by: Frane Ivasovic, et al.
Published: (2022-12-01)

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?
by: Ya-Lan Lin, et al.
Published: (2022-07-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

The role of ProBNP in differentiation of cardiogenic and non-cardiogenic syncope: A diagnostic accuracy study
by: Afshin Amini, et al.
Published: (2022-07-01)

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
by: Justin B. Echouffo‐Tcheugui, et al.
Published: (2023-06-01)

Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
by: Reza Mohebi, et al.
Published: (2023-10-01)

NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis
by: Su X, et al.
Published: (2023-05-01)

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
by: Noelia Costa-Rodríguez, et al.
Published: (2023-08-01)

NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
by: Marcus Vinicius Bolivar Malachias, et al.
Published: (2022-05-01)

Preoperative routine measurement of NT-proBNP predicts postoperative morbidity after non-cardiac surgery with intermediate or high surgical risk: an observational study
by: Götz Schmidt, et al.
Published: (2024-03-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
by: Hussein Alawieh, et al.
Published: (2019-11-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

Express test for NT-proBNP competitive detection based on lateral flow immunoassay using silanized fluorescent quantum dots
by: Olga A. Goryacheva, et al.
Published: (2023-08-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

SST2 and NT-proBNP biomarkers in prediction of COVID-19
by: O.O. Samchuk, et al.
Published: (2023-06-01)

Serial, Repeated, or Single Measurements of Natriuretic Peptides (BNP or NT‐proBNP) in Estimating Cardiovascular Risk: Is It the “Importance of Change Over Time” or “The Past Is Good, But the Present Is Better,” or Both, in Clinical Context?
by: Wayne L. Miller
Published: (2022-04-01)

Ultrasensitive and Rapid Detection of N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Using Fiber Optic Nanogold-Linked Immunosorbent Assay
by: Han-Long Liu, et al.
Published: (2022-09-01)

Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS-
by: Akira Suda, et al.
Published: (2022-12-01)

CHANGES IN THE LEVEL OF NT-proBNP AND MEAN PULMONARY ARTERY PRESSURE FOLLOWING BRONCHOPLASTIC LOBECTOMY OR PNEUMONECTOMY AS MARKERS OF RIGHT VENTRICULAR DYSFUNCTION
by: V. F. Larin, et al.
Published: (2021-03-01)

Adenotonsiller Hipertrofi Olan Çocuklarda Adenotonsillektominin N-Terminal Pro-Beyin Natriüretik Peptid (NT-ProBNP) Düzeylerine Etkileri
by: Metin Çeliker, et al.
Published: (2017-11-01)

Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology
by: Rosanna Rossi, et al.
Published: (2024-03-01)

РОЛЬ МОЗКОВОГО НАТРІЙУРЕТИЧНОГО ПЕПТИДУ (BNP) ТА NT-PRO-МОЗКОВОГО НАТРІЙУРЕТИЧНОГО ПЕПТИДУ (NT-PRO-BNP) В ДІАГНОСТИЦІ СЕРЦЕВОЇ НЕДОСТАТНОСТІ У ПАЦІЄНТІВ З ХРОНІЧНОЮ ХВОРОБОЮ НИРОК V СТАДІЇ
by: M. Kolesnyk, et al.
Published: (2017-12-01)

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
by: Michele Senni, et al.
Published: (2022-12-01)

The level of the cardiac peptide NT-proBNP and indices of the scale of assessment of clinical status in chronic heart failure patients with ischemic cardiomyopathy
by: E. I. Myasoedova, et al.
Published: (2016-06-01)

NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis
by: Mustafa Aytek Şimşek, et al.
Published: (2020-07-01)

NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
by: Juan Martínez-Milla, et al.
Published: (2022-07-01)

Estimation of GCF and Salivary Levels of NT-proBNP in Systemically Healthy Subjects with Severe Chronic Periodontitis Before and After Periodontal Flap Surgery
by: Ari G, et al.
Published: (2023-05-01)

Risk factors for pre‐heart failure or symptomatic heart failure based on NT‐proBNP
by: Shoko Aoki, et al.
Published: (2023-02-01)